C9-11289. Schedules of Controlled Substances: Proposed Placement of Zaleplon into Schedule IV  

  • [Federal Register Volume 64, Number 90 (Tuesday, May 11, 1999)]
    [Corrections]
    [Page 25405]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: C9-11289]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF JUSTICE
    
    Drug Enforcement Administration
    [DEA-182P]
    
    21 CFR Part 1308
    
    
    Schedules of Controlled Substances: Proposed Placement of 
    Zaleplon into Schedule IV
    
    Correction
    
        In proposed rule document 99-11289, beginning on page 24094 in the 
    issue of Wednesday May 5, 1999, make the following corrections:
        1. On page 24094, in the third column, beginning in the eighth line 
    from the bottom, the sentence ``Zaleplon-related overdoes were also 
    noted during the clinical trials'' is removed.
        2. On the same page, in the same column, in the fifth line from the 
    bottom, ``overdoes'' should read ``overdoses''.
    [FR Doc. C9-11289 Filed 5-10-99; 8:45 am]
    BILLING CODE 1505-01-D
    
    
    

Document Information

Published:
05/11/1999
Department:
Drug Enforcement Administration
Entry Type:
Correction
Document Number:
C9-11289
Pages:
25405-25405 (1 pages)
Docket Numbers:
DEA-182P
PDF File:
c9-11289.pdf
CFR: (1)
21 CFR 1308